The growing interest in NAD+ formulations, particularly at higher doses like 1000mg, is coinciding with the rising profile of Retatrutide – a groundbreaking GLP-1 receptor activator gaining attention https://webcastlist.com/story23811428/nad-product-the-new-drug-a-british-focus